Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Farallon Capital Management is a leading American multi-strategy investment firm and hedge fund headquartered in San Francisco. Founded in 1986 by Tom Steyer, it manages over $39–$42 billion in assets for university endowments, foundations, high-net-worth individuals, and institutional investors. The firm invests globally across asset classes including equities, credit instruments, real estate, private equity/debt and direct investments. It has a reputation for pioneering absolute return investing and event-driven international strategies. As of 2024–2025 it remains active with more than 340 employees across seven offices worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Farallon Capital Management.